JP7381469B2 - 新生児抗痙攣薬としてのグルコースオキシダーゼ組成物 - Google Patents

新生児抗痙攣薬としてのグルコースオキシダーゼ組成物 Download PDF

Info

Publication number
JP7381469B2
JP7381469B2 JP2020537006A JP2020537006A JP7381469B2 JP 7381469 B2 JP7381469 B2 JP 7381469B2 JP 2020537006 A JP2020537006 A JP 2020537006A JP 2020537006 A JP2020537006 A JP 2020537006A JP 7381469 B2 JP7381469 B2 JP 7381469B2
Authority
JP
Japan
Prior art keywords
clc
neonatal
nagca
gluconate
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020537006A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019136168A5 (https=
JP2021509671A5 (https=
JP2021509671A (ja
Inventor
ゴン チェン，
ジェン ウー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penn State Research Foundation
Original Assignee
Penn State Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/860,966 external-priority patent/US10213491B2/en
Application filed by Penn State Research Foundation filed Critical Penn State Research Foundation
Publication of JP2021509671A publication Critical patent/JP2021509671A/ja
Publication of JPWO2019136168A5 publication Critical patent/JPWO2019136168A5/ja
Publication of JP2021509671A5 publication Critical patent/JP2021509671A5/ja
Application granted granted Critical
Publication of JP7381469B2 publication Critical patent/JP7381469B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2020537006A 2018-01-03 2019-01-03 新生児抗痙攣薬としてのグルコースオキシダーゼ組成物 Active JP7381469B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/860,966 US10213491B2 (en) 2015-05-19 2018-01-03 Glucose oxidase compositions as a neonate anticonvulsant
US15/860,966 2018-01-03
PCT/US2019/012208 WO2019136168A1 (en) 2018-01-03 2019-01-03 Glucose oxidase compositions as a neonate anticonvulsant

Publications (4)

Publication Number Publication Date
JP2021509671A JP2021509671A (ja) 2021-04-01
JPWO2019136168A5 JPWO2019136168A5 (https=) 2022-01-14
JP2021509671A5 JP2021509671A5 (https=) 2022-01-14
JP7381469B2 true JP7381469B2 (ja) 2023-11-15

Family

ID=67143949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020537006A Active JP7381469B2 (ja) 2018-01-03 2019-01-03 新生児抗痙攣薬としてのグルコースオキシダーゼ組成物

Country Status (5)

Country Link
US (1) US11666640B2 (https=)
EP (1) EP3735262A4 (https=)
JP (1) JP7381469B2 (https=)
CN (1) CN112105378B (https=)
WO (1) WO2019136168A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111440771A (zh) * 2020-03-17 2020-07-24 中山大学附属第三医院 一种含有clcn2纯合突变的白质脑病患者特异诱导多能干细胞系

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016517885A (ja) 2013-04-30 2016-06-20 マサチューセッツ インスティテュート オブ テクノロジー 糖尿病を処置するための注射可能なナノネットワークゲル
US20160338980A1 (en) 2015-05-19 2016-11-24 Penn State Research Foundation Gluconate-Based Compositions As A Neonate Anticonvulsant

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364634A (en) 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
US6020317A (en) 1993-02-19 2000-02-01 Nippon Shinyaku Co. Ltd. Glycerol derivative, device and pharmaceutical composition
AU7166200A (en) * 1995-12-27 2001-03-08 Genencor International, Inc. Process for the preparation of gluconic acid and gluconic acid produced thereby
US5994316A (en) 1996-02-21 1999-11-30 The Immune Response Corporation Method of preparing polynucleotide-carrier complexes for delivery to cells
EP0914096B1 (en) 1996-05-17 2003-08-13 Elan Drug Delivery Limited Microparticles and their use in wound therapy
US20100029613A1 (en) 2004-11-15 2010-02-04 University Of Rochester Treatment and prevention of epilepsy
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
CN101626779B (zh) * 2007-02-28 2012-09-05 森永乳业株式会社 口腔内用杀菌剂和含有该杀菌剂的食品添加剂
DK2276505T3 (da) 2008-03-20 2013-11-25 Krister Tano Næsespray eller næsedråber til behandling af forkølelse
WO2012050895A1 (en) 2010-09-28 2012-04-19 Lisa Geng Methods for treating neurological disorders using nutrient compositions
WO2014165566A1 (en) 2013-04-03 2014-10-09 Emory University Hydrophilic particle compositions, processes of production, and uses in dietary management and digestive disorders
WO2015134490A1 (en) 2014-03-03 2015-09-11 The Penn State Research Foundation Self-powered enzyme micropumps
CN104450806B (zh) * 2014-11-27 2018-01-16 江南大学 一种酶法制备葡萄糖酸钠的方法
US10213491B2 (en) 2015-05-19 2019-02-26 The Penn State Research Foundation Glucose oxidase compositions as a neonate anticonvulsant
CN106978451B (zh) * 2017-03-29 2020-04-28 华南理工大学 一种固定化葡萄糖氧化酶制备葡萄糖酸钠的方法
CN106929500A (zh) * 2017-04-27 2017-07-07 南京工业大学 葡萄糖氧化酶/过氧化氢酶的交联酶聚体的制备方法及其应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016517885A (ja) 2013-04-30 2016-06-20 マサチューセッツ インスティテュート オブ テクノロジー 糖尿病を処置するための注射可能なナノネットワークゲル
US20160338980A1 (en) 2015-05-19 2016-11-24 Penn State Research Foundation Gluconate-Based Compositions As A Neonate Anticonvulsant

Also Published As

Publication number Publication date
CN112105378A (zh) 2020-12-18
EP3735262A1 (en) 2020-11-11
EP3735262A4 (en) 2021-09-29
CN112105378B (zh) 2025-03-11
US20200345817A1 (en) 2020-11-05
US11666640B2 (en) 2023-06-06
WO2019136168A1 (en) 2019-07-11
JP2021509671A (ja) 2021-04-01

Similar Documents

Publication Publication Date Title
Côté et al. Exercise modulates chloride homeostasis after spinal cord injury
Sharma et al. Astaxanthin ameliorates behavioral and biochemical alterations in in-vitro and in-vivo model of neuropathic pain
Xiao et al. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation
Li et al. Angiotensin II attenuates synaptic GABA release and excites paraventricular-rostral ventrolateral medulla output neurons
Hendricson et al. Aberrant synaptic activation of N-methyl-D-aspartate receptors underlies ethanol withdrawal hyperexcitability
Aroniadou-Anderjaska et al. Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors
Drever et al. Memantine acts as a cholinergic stimulant in the mouse hippocampus
Raghuraman et al. Activation of microglia in acute hippocampal slices affects activity-dependent long-term potentiation and synaptic tagging and capture in area CA1
Güttinger et al. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts
TWI452039B (zh) 抗神經變性疾病用劑
Yamamoto et al. Suppression of a neocortical potassium channel activity by intracellular amyloid-β and its rescue with Homer1a
Wang et al. Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain
Veronesi et al. Thyrotropin-releasing hormone d, l polylactide nanoparticles (TRH-NPs) protect against glutamate toxicity in vitro and kindling development in vivo
CN108289875A (zh) 苏糖酸盐化合物及其使用方法
Han et al. D-Serine rescues the deficits of hippocampal long-term potentiation and learning and memory induced by sodium fluoroacetate
Yang Ceramide-induced sustained depression of synaptic currents mediated by ionotropic glutamate receptors in the hippocampus: an essential role of postsynaptic protein phosphatases
Uwera et al. A novel mechanism for the anticonvulsant effect of furosemide in rat hippocampus in vitro
Qi et al. Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo
Zhao et al. Functional response of hippocampal CA1 pyramidal cells to neonatal hypoxic-ischemic brain damage
US10213491B2 (en) Glucose oxidase compositions as a neonate anticonvulsant
Yu et al. Endophilin A1 mediates seizure activity via regulation of AMPARs in a PTZ-kindled epileptic mouse model
JP7381469B2 (ja) 新生児抗痙攣薬としてのグルコースオキシダーゼ組成物
US9861597B2 (en) Gluconate-based compositions as a neonate anticonvulsant
Qian et al. Astrocytic glutamate transporter-dependent neuroprotection against glutamate toxicity: an in vitro study of maslinic acid
Goussakov et al. Occlusion of activity dependent synaptic plasticity by late hypoxic long term potentiation after neonatal intermittent hypoxia

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211229

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211229

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221102

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230425

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230724

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230925

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231010

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231102

R150 Certificate of patent or registration of utility model

Ref document number: 7381469

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150